Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
ESMO Open|June 19, 2021
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) SurveyP Garrido, A A Adjei, J Bajpai, et al.
ESMO Open|November 7, 2025
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumorsR Dienstmann, A Vivancos, P Nuciforo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2017
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout SurveyS Banerjee, R Califano, J Corral, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ Y Douillard, S Siena, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyM Tempero, D-Y Oh, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principleL De Mattos-Arruda, B Weigelt, J Cortes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 30, 2021
Future care for long-term cancer survivors: towards a new modelM Provencio, N Romero, J Tabernero, et al.
ESMO Open|February 22, 2025
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2S Stintzing, J Tabernero, T Satoh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2020
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumorsS J Isakoff, J Tabernero, L R Molife, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapyJ Vidal, B Bellosillo, C Santos Vivas, et al.
Pageof 18